Interestingly, a report also showed that SHMT2 drove the progression of colorectal cancer by inhibiting the degradation of β-catenin to promote Wnt/β-catenin signaling in a non-metabolic manner [7]. The gene discussed is SHMT2; the disease is colorectal cancer.